Teladoc Q4 revenue flat at $642M, net loss narrows; FY2026 revenue guidance $2.47-2.587B

Teladoc Health, Inc.

2025-FY EPS reported -$1.14 revenue$2,529,977,000

Q4 2025 revenue $642.3M (flat YoY); net loss $25.1M vs $48.4M loss; adjusted EBITDA $83.8M (+12% YoY).
Full year 2025 revenue $2.53B (-2% YoY); net loss $200.3M vs $1.001B loss (lower goodwill impairment).
Integrated Care segment revenue +5% in Q4; BetterHelp -7%. FY Integrated Care adjusted EBITDA +3% to $239.2M.
FY2026 revenue guidance $2.47-2.587B; adjusted EBITDA $266-308M; free cash flow $130-170M.
Cash and equivalents $781.1M at year-end; Q4 free cash flow $53.4M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.